Erlotinib Completed Phase 1 Trials for Cancer of the Gallbladder / Malignant Neoplasm of Pancreas / Liver Cancer / Periampullary Adenocarcinoma / Extrahepatic Bile Duct Cancer / Small Intestine Cancer Treatment

Indications	Status	Purpose	Phase
DBCOND0034881 (Cancer of the Gallbladder) DBCOND0087260 (Malignant Neoplasm of Pancreas) DBCOND0028488 (Liver Cancer) DBCOND0042952 (Periampullary Adenocarcinoma) DBCOND0028665 (Extrahepatic Bile Duct Cancer) DBCOND0028490 (Small Intestine Cancer)	Completed	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT00987766	Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer	Erlotinib (DB00530) Gemcitabine (DB00441) Oxaliplatin (DB00526)